Maternal and Fetal Outcomes in Pregnant Women With COVID -19,a Cross Sectional Study
COVID-19 and Pregnancy Maternal and Fetal Outcomes,A Retrospective Cross Sectional Study
1 other identifier
observational
70
1 country
1
Brief Summary
The spread of a new coronavirus (SARS-CoV-2) from Wuhan, China, has been fast, and the World Health Organization (WHO) declared a pandemic on March 11th, 2020 .It has now spread worldwide and is one of the most severe public health threats.The clinical characteristics of COVID-19 and the likelihood of transmission vertically or during delivery in pregnant women are still unknown.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 5, 2022
CompletedFirst Posted
Study publicly available on registry
November 8, 2022
CompletedNovember 8, 2022
November 1, 2022
5 months
November 5, 2022
November 5, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Outcomes of Pregnancy with COVID-19
Prevalence of maternal and fetal morbidities and adverse obstetrical outcomes among pregnant women with COVID-19 diagnosis.
32 months
Eligibility Criteria
A retrospective analysis of prospectively collected data of pregnant women confirmed as COVID-19 infected. Maternal and fetal morbidities and adverse obstetrical outcomes among those with COVID-19 will be analyzed. Maternal outcomes will include:Venous thromboembolic events,pregnancy outcome,mode of delivery,frequency of admission to ICU,need for assistive ventilation,mortality rate Fetal outcomes will include:Frequency of NICU admission,Preterm birth,Intrauterine growth restriction,Intrauterine fetal death,Congenital fetal malformations.
You may qualify if:
- Pregnant women of any gestational age with confirmed COVID 19 diagnosis attended and admitted at inpatient ward for management and follow up from April 2020 to December 2021at Kasr El Ainy hospital,Cairo university
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University
Giza, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer at Obstetrics and Gynecology department
Study Record Dates
First Submitted
November 5, 2022
First Posted
November 8, 2022
Study Start
April 1, 2022
Primary Completion
September 1, 2022
Study Completion
October 1, 2022
Last Updated
November 8, 2022
Record last verified: 2022-11